Nexalin Technology (NXL) Net Cash Flow (2021 - 2026)
Nexalin Technology (NXL) posted Net Cash Flow of -$202937.0 for Q2 2026, down 136.69% on a QoQ basis from $553112.0 in Q1 2026, and up 95.8% year-over-year from -$103642.6 in Q2 2025.
Powered by 
Analysis
Nexalin Technology (NXL) Net Cash Flow (2021 - 2026) Analysis & Trends
Nexalin Technology has reported Net Cash Flow for 6 years, with the latest figure at -$202937.0 in Q2 2026.
- On a quarterly basis, Net Cash Flow rose 95.8% year-over-year to -$202937.0 in Q2 2026; TTM through Jun 2026 was $573638.0, a 105.99% increase from a year earlier, with the FY2025 full-year figure at $80298.0, up 1497.7% from the prior year.
- Net Cash Flow was -$202937.0 for Q2 2026 at Nexalin Technology, down from $553112.0 in the prior quarter.
- The five-year high for Net Cash Flow was $7.6 million in Q3 2022, with the low at -$5.3 million in Q3 2024.
- Average Net Cash Flow over 5 years is -$112473.4, with a median of $52152.5 recorded in 2023.
- The sharpest annual moves came in 2024 and 2026: Net Cash Flow slumped 4174.46% in 2024, then jumped 1063.37% in 2026.
- Over 5 years, Net Cash Flow stood at -$906457.0 in 2022, then jumped by 124.14% to $218834.0 in 2023, then surged by 125.31% to $493064.0 in 2024, then tumbled by 86.88% to $64708.0 in 2025, then slumped by 413.62% to -$202937.0 in 2026.
- The last three Net Cash Flow figures came in at -$202937.0 (Q2 2026), $553112.0 (Q1 2026), and $64708.0 (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 179.79 Bn | 174.18 Bn | 7.27 Bn | -1.70 Bn |
| 2 | Intuitive Surgical | 127.69 Bn | 122.47 Bn | 1.96 Bn | 746.50 Mn |
| 3 | Medtronic | 117.23 Bn | 108.41 Bn | 6.34 Bn | -169.00 Mn |
| 4 | Stryker | 103.55 Bn | 100.07 Bn | 4.50 Bn | 527.00 Mn |
| 5 | Boston Scientific | 63.24 Bn | 62.70 Bn | 3.85 Bn | -892.00 Mn |
| 6 | Edwards Lifesciences | 49.97 Bn | 45.72 Bn | 1.35 Bn | 458.40 Mn |
| 7 | Alcon | 32.83 Bn | 31.37 Bn | 1.68 Bn | -222.00 Mn |
| 8 | Dexcom | 32.30 Bn | 30.35 Bn | 830.00 Mn | -8.30 Mn |
| 9 | Steris | 20.73 Bn | 20.25 Bn | 684.20 Mn | 45.10 Mn |
| 10 | Nexalin Technology | 3.44 Mn | 2.44 Mn | 8,897.00 | -202,937.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -202,937.00 |
| Mar 31, 2026 | 553,112.00 |
| Dec 31, 2025 | 64,708.00 |
| Sep 30, 2025 | 158,755.00 |
| Jun 30, 2025 | -4.84 Mn |
| Mar 31, 2025 | 47,544.00 |
| Dec 31, 2024 | 493,064.00 |
| Sep 30, 2024 | -5.28 Mn |
| Jun 30, 2024 | 302,541.00 |
| Mar 31, 2024 | -33,975.00 |
| Dec 31, 2023 | 218,834.00 |
| Sep 30, 2023 | 129,675.00 |
| Jun 30, 2023 | 56,761.00 |
| Mar 31, 2023 | 12,218.00 |
| Dec 31, 2022 | -906,457.00 |
| Sep 30, 2022 | 7.57 Mn |
| Jun 30, 2022 | -167,272.00 |
| Mar 31, 2022 | -203,171.00 |
| Dec 31, 2021 | 525,352.00 |